Related Experiment Video
Updated: Dec 22, 2025
Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
Improving function in people with hip-related pain: a systematic review and meta-analysis of physiotherapist-led
Joanne L Kemp1, Andrea B Mosler2, Harvi Hart2,3
1Latrobe Sports Exercise Medicine Research Centre, School of Allied Health, Human Services and Sport, La Trobe University, Bundoora, Victoria, Australia j.kemp@latrobe.edu.au.
Objective:
To report the effectiveness of physiotherapist-led interventions in improving pain and function in young and middle-aged adults with hip-related pain.
Design:
Systematic review and meta-analysis.
Data Sources:
A comprehensive, reproducible search strategy was performed on five databases in May 2019. Reference lists and grey literature were also searched.
Eligibility Criteria For Selecting Studies:
Population: people aged ≥18 years with hip-related pain (with or without a diagnosis of femoroacetabular impingement syndrome).
Intervention(S):
physiotherapist-led interventions for hip pain. Comparators: sham treatment, no treatment or other treatment (eg, hip arthroscopic surgery).
Outcomes:
primary outcomes included patient-reported hip pain and function. Secondary outcomes included physical function measures.
Results:
1722 papers were identified. After exclusion criteria were applied, 14 studies were included for analysis. They had varied risk of bias. There were no full-scale placebo-controlled randomised controlled trials (RCTs) of physiotherapist-led treatment. Pooled effects ranged from moderate effects (0.67 (95% CI 0.07 to 1.26)) favouring physiotherapist-led intervention over no treatment post-arthroscopy, to weak effects (-0.32 (95% CI 0.57 to 0.07)) favouring hip arthroscopy over physiotherapist-led treatment.
Conclusion:
Physiotherapist-led interventions might improve pain and function in young and middle-aged adults with hip-related pain, however full-scale high-quality RCT studies are required.
Prospero Registration Number:
CRD42018089088.
